- Advertise
- About OncLive
- Editorial Board
- CureToday.com
- TargetedOnc.com
- CancerNetwork.com
- Contact Us
- Privacy
- Terms & Conditions
- Do Not Sell My Information
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
© 2021 MJH Life Sciences™ and OncLive. All rights reserved.
UCSD Moores Cancer Center | Strategic Alliance Partners
Our unique blend of cancer research and patient care is transforming cancer prevention, detection and treatment. Established in 1978, Moores Cancer Center is the region’s only National Cancer Institute-designated Comprehensive Cancer Center. This designation is reserved for centers with the highest achievements in cancer research, clinical care, education and community contributions.
Latest from UCSD Moores Cancer Center
Dr. Jamieson on the Importance of Treating at Diagnosis in Myelofibrosis
August 12, 2021
Video
Catriona Jamieson, MD, PhD, discusses the importance of treating patients with myelofibrosis at diagnosis.
Making the Most of Molecular Testing in Breast Cancer
August 12, 2021
Podcast
Drs. Brown and Kurzrock discuss the current and future applications of next-generation sequencing in breast cancer, the role of tissue-based testing in light of the growing role for liquid-based testing, and some of the emerging technologies that could overcome current barriers to biomarker testing.
Dr. Patel on the Potential With PARP/Immunotherapy Combos in NSCLC
July 30, 2021
Video
Sandip P. Patel, MD, discusses the potential of combining PARP inhibitors with immunotherapy for patients with non–small cell lung cancer.
UCSD Faculty Contextualize Cases of Cutaneous Squamous Cell Carcinoma
May 20, 2021
Podcast
Drs Park, Daniels, Sanghvi, and Kolb, discuss two high-risk non-melanoma skin cancer cases and highlighted patient and tumor risk factors to consider in the clinical setting.
Designer DNA Therapeutic Wipes Out Cancer Stem Cells, Treats Multiple Myeloma in Mice
April 23, 2021
Article
Study supports launch of Phase I clinical trial to test a designer DNA agent — an antisense oligonucleotide that targets a gene called IRF4 — in patients with multiple myeloma
Study Uses Precision Medicine to Speed Drug Testing for Pancreatic Cancer
April 22, 2021
Article
Moores Cancer Center at UC San Diego Health is among the few clinical trial sites in the U.S. for the Pancreatic Cancer Action Network’s newly created Precision Promise, the first large-scale precision medicine trial designed to transform outcomes for patients with pancreatic cancer.